Syngene International has appointed Siddharth Mittal as its Managing Director and Chief Executive Officer, effective July 1, 2026. The leadership change marks a strategic transition for the global contract research, development, and manufacturing organization (CRDMO) as it aims to strengthen its commercial edge and operational excellence. Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on June 30, 2026.

Mittal brings nearly three decades of business leadership experience to the role. He joins Syngene International from Biocon Limited, where he most recently served as the Managing Director and Chief Executive Officer. During his thirteen-year tenure at Biocon, he held the position of Chief Financial Officer before being appointed to the top leadership role. His tenure included securing key regulatory approvals and commercializing the GLP-1 portfolio across major international markets.

Kiran Mazumdar-Shaw, Executive Chairperson of Syngene International, expressed confidence in the new appointment. She stated that Syngene is at an inflection point and that Mittal's leadership, commercial acumen, and execution focus will help the company unlock its full potential. She highlighted his ability to lead businesses through periods of change and deliver sustainable growth.

Commenting on his new role, Siddharth Mittal said his immediate priority is to sharpen the company's commercial edge and strengthen delivery excellence. He emphasized combining scientific strengths with a focus on customer fulfilment and cost-competitiveness to restore growth momentum. Mittal aims to reinforce Syngene's standing as a global leader in CRDMO services.

Key Leadership Transition

The following table summarizes the key details of the leadership change at Syngene International:

Syngene International shareholders have approved the transition of Ms. Kiran Mazumdar-Shaw from Non-Executive Chairperson to Executive Chairperson, a Key Managerial Personnel, along with the payment of managerial remuneration. The special resolution was passed with the requisite majority on June 19, 2026, the last date of receipt of postal ballot e-voting. This change elevates the role of the founder within the company's management structure.

The postal ballot process, conducted entirely through remote e-voting from May 21, 2026, to June 19, 2026, saw significant participation across shareholder categories. A total of 351,342,683 votes were polled, representing 87.19% of the company's outstanding shares. The resolution secured approval with 91.4% of the valid votes cast, despite opposition from a section of public institutional shareholders.

Voting Breakdown

The voting pattern revealed a divergence between promoter and public institutional shareholders. While the promoter group voted overwhelmingly in favour, public institutions showed significant dissent. The following table details the voting distribution across key categories:

Procedural Details

The Scrutinizer's Report, submitted by V Sreedharan & Associates, confirmed the validity of the process pursuant to Section 110 of the Companies Act, 2013. The report noted that the notice was dispatched electronically on April 29, 2026, and advertisements were published in the Financial Express and Vijayavani on May 21, 2026. The record date for determining eligibility was May 15, 2026, at which point the company had 146,402 shareholders on its register.

The resolution required a special majority due to the alteration in the role of a Key Managerial Personnel. The total paid-up equity capital as on the cut-off date of May 15, 2026, stood at 4,029,394,20 equity shares of ₹10 each. The results of the remote e-voting and the Scrutinizer's Report are available on the company's website and the portal of KFin Technologies Limited, the Register and Share Transfer Agents.